Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: A case study

Journal of Dermatological Treatment

Volumn 17, Issue 3, 2006, Pages 172-175

  Gisondi, Paolo ^a   Giglio, Micol Del ^a   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Concomitant; Continuous; Efalizumab; Psoriasis; Worsening

Indexed keywords

CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETRETIN; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; SCORING SYSTEM; SHORT COURSE THERAPY; SYMPTOM;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MALE; METHOTREXATE; MIDDLE AGED; PSORIASIS;

EID: 33746641339     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630600714279     Document Type: Article

References (9)

1. Capon F, Dallapiccola B, Novelli G. Advances in the search for psoriasis susceptibility genes. Mol Genet Metab. 2000;71:250-5.
2. Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, et al. Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol. 2004;151(suppl 69), 3-17.
3. Jullien D, Prinz JC, Langley RG, Caro I, Dummer W, Joshi A, et al. T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): Mechanisms of action. Dermatology. 2004;208:297-306.
4. Cather JC, Menter A. Efalizumab: Continuous therapy for chronic psoriasis. Expert Opin Biol Ther. 2005;5:393-403.
5. Raptiva prescribing information (US). June 2005.
6. Lebwohl M. A clinician's paradigm in the treatment of psoriasis. J Am Acad Dermatol. 2005;53:S59-S69.
7. De Jong EM. The course of psoriasis. Clin Dermatol. 1997;15:687-92.
8. Cather JC, Menter A. Combining traditional agents and biologics for the treatment of psoriasis. Semin Cutan Med Surg. 2005;24:37-45.
9. Pearce DJ, Nelson AA, Fleischer AB, Balkrishnan R, Feldman SR. The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies. J Dermatolog Treat. 2006;17:29-37.